Jones Financial Companies
GNPX icon

Jones Financial Companies’s Genprex GNPX Stock Holding History

Jones Financial Companies’s Portfolio GNPX Stock Details GNPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$597 Sell
55
-41
-43% -$787 ﹤0.01% 4723
2026
Q1 		$3.83K Buy
96
+48
+100% +$2.29K ﹤0.01% 3943
2025
Q4 		$1.85K Buy
+48
New +$6.75K ﹤0.01% 3839

Other funds holding GNPX

Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EGM
Engineers Gate Manager New York $7.71B AUM 24.88% 1-Year Est. Return
MFA
Mayflower Financial Advisors Boston, Massachusetts $1.16B AUM 24.36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
CVM
Cheviot Value Management Beverly Hills, California $984M AUM 24.46% 1-Year Est. Return

Jones Financial Companies's GNPX Position: Q2 2026 in Review

Jones Financial Companies reduced its Genprex (GNPX) stake by 43% in Q2 2026, selling an estimated $787 and leaving 55 shares worth $597. The position accounts for ﹤0.01% of the portfolio, ranked #4723.

Jones Financial Companies first reported a position in GNPX in Q4 2025 and has held it in 3 quarters since. The position peaked at $3.83K in Q1 2026. 17 funds tracked by Wall St. Rank hold GNPX as of Q2 2026.

  • Jones Financial Companies held 55 shares of Genprex worth $597 as of Q2 2026.
  • Jones Financial Companies sold 41 Genprex shares in Q2 2026, an estimated $787.
  • Genprex made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #4723 holding.
  • Jones Financial Companies first reported a position in Genprex in Q4 2025 and has held it in 3 quarters since.
  • Jones Financial Companies's Genprex position peaked at $3.83K in Q1 2026.
  • 17 funds tracked by Wall St. Rank held Genprex as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.